Prolonged-Release Potassium Chloride Generics Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 8 mEq (600 mg), 10 mEq (750 mg), 15mEq (1,125 mg), 20mEq (1,500 mg)
Reference Brands: Klor-Con®, K-Dur®, K-Tab®, Micro-K® (US), KCl Retard®, Kaleorid®, Kalium-Retard®, Slow-K® (EU)
Category:
Nephrology
Prolonged-release Potassium Chloride is an oral electrolyte supplement used to treat and prevent hypokalemia, especially in CKD and patients on diuretics, offering controlled potassium release for stable serum levels.
Prolonged-release Potassium Chloride Generics is available in Tablet
and strengths such as 8 mEq (600 mg), 10 mEq (750 mg), 15mEq (1,125 mg), 20mEq (1,500 mg).
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Prolonged-release Potassium Chloride Generics is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Prolonged-release Potassium Chloride Generics can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Prolonged-release Potassium Chloride is a vital electrolyte supplement used to treat and prevent hypokalemia in patients with chronic kidney disease (CKD), heart conditions, or those on diuretic therapy. Designed for steady potassium release, it helps maintain optimal serum potassium levels, reducing the risk of cardiac arrhythmias and muscle dysfunction. Widely prescribed in both the US and EU, it plays a crucial role in nephrology and cardiology. Ideal for B2B pharmaceutical supply, it is available in various strengths to meet diverse patient needs. Prolonged-release Potassium Chloride supports safe, effective potassium repletion in renal and electrolyte management protocols.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing